Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Bridgeman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|December 24, 2021
The HDAC Inhibitor Butyrate Impairs β Cell Function and Activates the Disallowed Gene Hexokinase IStephanie Bridgeman, Gaewyn Ellison, Philip Newsholme, et al.
International Journal of Molecular Sciences|December 23, 2022
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 SignallingStephanie Bridgeman, Hon Chiu Woo, Philip Newsholme, et al.
Cancers|April 13, 2019
Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying EnzymesStephanie Bridgeman, Wendy Northrop, Gaewyn Ellison, et al.
The Journal of Clinical Investigation|September 24, 2025
USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancerNishi Kumari, Sarah Ce Wright, Christopher M Witham, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|December 24, 2021
The HDAC Inhibitor Butyrate Impairs β Cell Function and Activates the Disallowed Gene Hexokinase IStephanie Bridgeman, Gaewyn Ellison, Philip Newsholme, et al.
International Journal of Molecular Sciences|December 23, 2022
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 SignallingStephanie Bridgeman, Hon Chiu Woo, Philip Newsholme, et al.
Cancers|April 13, 2019
Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying EnzymesStephanie Bridgeman, Wendy Northrop, Gaewyn Ellison, et al.
The Journal of Clinical Investigation|September 24, 2025
USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancerNishi Kumari, Sarah Ce Wright, Christopher M Witham, et al.
Pageof 1